Nanotechnology: Detection & Analysis of Plaque Formation

纳米技术:检测

基本信息

  • 批准号:
    7234692
  • 负责人:
  • 金额:
    $ 223.59万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2005
  • 资助国家:
    美国
  • 起止时间:
    2005-05-15 至 2010-04-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): This PEN application aims to establish a highly collaborative and multidisciplinary Program of Excellence in Nanotechnology by integrating the bioengineering expertise of Georgia Tech (Atlanta, GA) and the cardiology strengths of Emory University School of Medicine (Atlanta, GA). The broad and long-term goal of this PEN is to develop nanotechnology and biomolecular engineering tools and methodologies for the detection and molecular analysis of atherosclerotic plaque formation, which has a compelling medical need. Cardiovascular disease remains the leading cause of death in the United States: One out of every four Americans has cardiovascular disease, and every 30 seconds one person dies from this disease. Although significant advances have been made in the management and treatment of this disease, there is still a lack of understanding of the fundamental biology and pathophysiology of atherosclerosis, especially the molecular mechanisms responsible for plaque formation. As a result, early detection of atherosclerotic plaque is difficult, leading to a high rate of morbidity and mortality. We propose to develop advanced nanotechnologies for molecular analysis of plaque formation and sensitive detection of plaques. Specifically: (1) we will develop the molecule beacon based technology for mRNA expression and localization in living cells in response to shear stress; (2) we will develop quantum dot (Qd) based probes for studying protein interactions in cells; (3) the QD probes will be further developed for in vivo detection and analysis of plaques; (4) we will develop magnetic nanoparticle probes for in vivo plaque detection; (5) we will carry out a pilot project to develop LDL and chymase based contrast agent for in vivo plaque detection; (6) as a second pilot project we will develop activatable probes for detecting oxidative stress in living cells. Underlying this PEN is a strong track record of the senior investigators who have worked together successfully in attracting joint research grants. In addition, the Department of Biomedical Engineering, which was jointly established in 1997 by Georgia Tech and Emory University School of Medicine, has presented unique opportunity for research collaboration and skill training by bring bioengineering, nanotechnologies and discoveries into medicine and vice versa. If funded, this Program of Excellence in Nanotechnology will be housed on the Emory Campus and with a truly outstanding environment for collaborative and translational cardiovascular research and training. In additional to basic knowledge on cardiology, this PEN is expected to yield methodologies that can direct impact on clinical practice of early detection, diagnosis and treatment of atherosclerosis.
描述(由申请人提供): 该笔申请旨在通过整合佐治亚理工学院的生物工程专业知识(佐治亚州亚特兰大)和埃默里大学医学院(佐治亚州亚特兰大)的心脏病学优势,以建立高度合作和多学科的纳米技术卓越课程。这支笔的广泛而长期的目标是开发纳米技术和生物分子工程工具和方法,用于对动脉粥样硬化斑块形成的检测和分子分析,这具有迫切的医疗需求。心血管疾病仍然是美国的主要死亡原因:每四个美国人中有一个患有心血管疾病,每30秒就死于这种疾病。尽管在该疾病的管理和治疗方面已经取得了重大进展,但仍缺乏对动脉粥样硬化的基本生物学和病理生理学的了解,尤其是导致斑块形成的分子机制。结果,难以早期检测动脉粥样硬化斑块,导致高发病率和死亡率高。我们建议开发晚期纳米技术,以分子分析斑块形成和斑块敏感检测。具体而言:(1)我们将开发基于灯塔的分子信标技术,以响应剪切应力而在活细胞中定位; (2)我们将开发基于量子点(QD)的探针,以研究细胞中的蛋白质相互作用; (3)QD探针将进一步开发用于体内检测和斑块分析; (4)我们将开发用于体内斑块检测的磁性纳米颗粒探针; (5)我们将执行一个试点项目,以开发基于LDL和基于Chymase的对比剂,以用于体内斑块检测; (6)作为第二个试点项目,我们将开发可激活的探针,以检测活细胞中的氧化应激。这支笔的基础是高级调查员成功地吸引联合研究补助金的高级调查员的良好记录。此外,佐治亚理工学院和埃默里大学医学院于1997年共同建立的生物医学工程系,通过将生物工程,纳米技术和发现带入医学以及反之亦然,为研究合作和技能培训提供了独特的机会。如果获得资助,该纳米技术卓越课程将安置在埃默里校园中,并为协作和转化的心血管研究和培训提供真正杰出的环境。除了心脏病学基础知识的其他知识外,预计该笔将产生对早期检测,诊断和治疗动脉粥样硬化的临床实践影响的方法。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Gang Bao其他文献

Gang Bao的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Gang Bao', 18)}}的其他基金

Deciphering unintended large gene modifications in gene editing for sickle cell disease
破译镰状细胞病基因编辑中意外的大基因修饰
  • 批准号:
    10720685
  • 财政年份:
    2023
  • 资助金额:
    $ 223.59万
  • 项目类别:
Precision mapping of regulatory causal variants by expression CROPseq
通过表达 CROPseq 精确绘制调控因果变异
  • 批准号:
    10095869
  • 财政年份:
    2021
  • 资助金额:
    $ 223.59万
  • 项目类别:
Precision mapping of regulatory causal variants by expression CROPseq
通过表达 CROPseq 精确绘制调控因果变异
  • 批准号:
    10557093
  • 财政年份:
    2021
  • 资助金额:
    $ 223.59万
  • 项目类别:
Precision mapping of regulatory causal variants by expression CROPseq
通过表达 CROPseq 精确绘制调控因果变异
  • 批准号:
    10341085
  • 财政年份:
    2021
  • 资助金额:
    $ 223.59万
  • 项目类别:
HBB gene-editing for treating sickle cell disease
HBB 基因编辑治疗镰状细胞病
  • 批准号:
    10609477
  • 财政年份:
    2020
  • 资助金额:
    $ 223.59万
  • 项目类别:
Addressing safety issues by quantify large deletions and chromosomal rearrangements in HBB gene editing
通过量化 HBB 基因编辑中的大缺失和染色体重排来解决安全问题
  • 批准号:
    10087778
  • 财政年份:
    2020
  • 资助金额:
    $ 223.59万
  • 项目类别:
HBB gene-editing for treating sickle cell disease
HBB 基因编辑治疗镰状细胞病
  • 批准号:
    10392986
  • 财政年份:
    2020
  • 资助金额:
    $ 223.59万
  • 项目类别:
Velcro AAV Vector for tissue-specific delivery of genome editing reagents with enhanced cargo capacity
Velcro AAV Vector 用于基因组编辑试剂的组织特异性递送,具有增强的负载能力
  • 批准号:
    9810928
  • 财政年份:
    2019
  • 资助金额:
    $ 223.59万
  • 项目类别:
Velcro AAV Vector for tissue-specific delivery of genome editing reagents with enhanced cargo capacity
Velcro AAV Vector 用于基因组编辑试剂的组织特异性递送,具有增强的负载能力
  • 批准号:
    10231050
  • 财政年份:
    2019
  • 资助金额:
    $ 223.59万
  • 项目类别:
Velcro AAV Vector for tissue-specific delivery of genome editing reagents with enhanced cargo capacity
Velcro AAV Vector 用于基因组编辑试剂的组织特异性递送,具有增强的负载能力
  • 批准号:
    10001604
  • 财政年份:
    2019
  • 资助金额:
    $ 223.59万
  • 项目类别:

相似海外基金

Soft wireless multimodal cardiac implantable devices for long-term investigating heart failure pathogenesis
用于长期研究心力衰竭发病机制的软无线多模式心脏植入装置
  • 批准号:
    10735395
  • 财政年份:
    2023
  • 资助金额:
    $ 223.59万
  • 项目类别:
Developing a novel disease-targeted anti-angiogenic therapy for CNV
开发针对 CNV 的新型疾病靶向抗血管生成疗法
  • 批准号:
    10726508
  • 财政年份:
    2023
  • 资助金额:
    $ 223.59万
  • 项目类别:
Validation of the joint-homing and drug delivery attributes of novel peptides in a mouse arthritis model
在小鼠关节炎模型中验证新型肽的关节归巢和药物递送特性
  • 批准号:
    10589192
  • 财政年份:
    2023
  • 资助金额:
    $ 223.59万
  • 项目类别:
Milk fat globule-EGF factor 8 and hepatocyte apoptosis-induced liver wound healing response
乳脂肪球-EGF因子8与肝细胞凋亡诱导的肝脏创面愈合反应
  • 批准号:
    10585802
  • 财政年份:
    2023
  • 资助金额:
    $ 223.59万
  • 项目类别:
Fecal Microbiota Transfer Attenuates Aged Gut Dysbiosis and Functional Deficits after Traumatic Brain Injury
粪便微生物群转移可减轻老年肠道菌群失调和脑外伤后的功能缺陷
  • 批准号:
    10573109
  • 财政年份:
    2023
  • 资助金额:
    $ 223.59万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了